UA88894C2 - Stable pharmaceutical solution formulation for pressurized metered dose inhalers - Google Patents
Stable pharmaceutical solution formulation for pressurized metered dose inhalersInfo
- Publication number
- UA88894C2 UA88894C2 UAA200608865A UAA200608865A UA88894C2 UA 88894 C2 UA88894 C2 UA 88894C2 UA A200608865 A UAA200608865 A UA A200608865A UA A200608865 A UAA200608865 A UA A200608865A UA 88894 C2 UA88894 C2 UA 88894C2
- Authority
- UA
- Ukraine
- Prior art keywords
- metered dose
- solution formulation
- dose inhalers
- stable pharmaceutical
- pharmaceutical solution
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Aerosol solution formulations for use in an aerosol inhaler which comprise 8-hydroxy-5-[(1R)-1-hydroxy-2-1[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone or a salt thereof, in particular the hydrochloride salt (ТА 2005), as an active ingredient, a propellant containing a hydrofluoroalkane, and a cosolvent, stabilized by addition of a specific small amount of a high concentrated phosphoric acid and optionally by the use of a suitable can having part or all of its internal metallic surfaces lined with an inert organic coating.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54779804P | 2004-02-27 | 2004-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA88894C2 true UA88894C2 (en) | 2009-12-10 |
Family
ID=37779269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200608865A UA88894C2 (en) | 2004-02-27 | 2005-02-25 | Stable pharmaceutical solution formulation for pressurized metered dose inhalers |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN100457087C (en) |
| UA (1) | UA88894C2 (en) |
| ZA (1) | ZA200606577B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3089735T3 (en) * | 2013-12-30 | 2018-12-31 | Chiesi Farmaceutici S.P.A. | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA939195B (en) * | 1992-12-09 | 1995-06-08 | Boehringer Ingelheim Pharma | Stabilized medicinal aerosol solution formulations |
| DE19847969A1 (en) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation |
| DZ2947A1 (en) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Pressure metered dose inhaler. |
| SK286694B6 (en) * | 2000-05-22 | 2009-03-05 | Chiesi Farmaceutici S.P.A. | Aerosol pharmaceutical composition |
| PT3494995T (en) * | 2002-03-01 | 2020-03-30 | Chiesi Farm Spa | Formoterol superfine formulation |
-
2005
- 2005-02-25 CN CNB2005800060603A patent/CN100457087C/en not_active Expired - Fee Related
- 2005-02-25 UA UAA200608865A patent/UA88894C2/en unknown
-
2006
- 2006-08-07 ZA ZA200606577A patent/ZA200606577B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200606577B (en) | 2009-04-29 |
| CN100457087C (en) | 2009-02-04 |
| CN1921835A (en) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN06250A1 (en) | Stable pharmaceutical solution formulations for pressurized metered dose inhalers | |
| MXPA02011414A (en) | Stable pharmaceutical solution formulations for pressurised metered dose inhalers. | |
| WO2007123945A3 (en) | Mechanical single dose intrapulmonary drug delivery devices | |
| TW200735870A (en) | Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation | |
| ATE308317T1 (en) | PREPARATIONS CONTAINING AN ANTICHOLINERGIC ACTIVE INGREDIENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
| WO2007095043A3 (en) | Pharmaceutical formulations | |
| EA200401019A1 (en) | DOSED MEDICAL FORM FOR ORAL APPLICATION CONTAINING PDE 4 INHIBITOR AS AN ACTIVE SUBSTANCE AND POLYVINYLPYRROLIDONE AS AN AUXILIARY | |
| WO2007047948A3 (en) | Intranasal administration of rapid acting insulin | |
| CA2352483A1 (en) | Pharmaceutical aerosol composition containing hfa 227 and hfa 134a | |
| CA2492976A1 (en) | Solution for ungual and peri-ungual application | |
| NZ517166A (en) | Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists | |
| PH12014501713A1 (en) | Novel pharmaceutical formulations | |
| WO2007020204A3 (en) | Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate | |
| CA2304135A1 (en) | Medicament formulation with a controlled release of an active agent | |
| TNSN07289A1 (en) | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent | |
| DE60225421D1 (en) | INHALER WITH AGENTS FOR IMPROVING THE CHEMICAL STABILITY OF A MEDICAL AEROSOL SOLUTION CONTAINING THEREIN | |
| WO2005044186A3 (en) | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same | |
| UA88894C2 (en) | Stable pharmaceutical solution formulation for pressurized metered dose inhalers | |
| JO2709B1 (en) | Stable Medicinal Solution Formulations for Pressurized Metered Dose Inhalers. | |
| NO20064359L (en) | Stable pharmaceutical solution formulation for pressurized dosage inhaler | |
| WO2002055022A3 (en) | Active metabolite of antifungal compound | |
| AR048418A1 (en) | FORMULATIONS OF STABLE MEDICINAL SOLUTIONS FOR PRESSURIZED CARTRIDGE INHALERS | |
| TH76283A (en) | Stable solution formulation for nebulization equipment. | |
| WO2005087192A3 (en) | Salmeterol inhalation formulations | |
| BR0303347A (en) | Aerosol formulations containing esters of 3,17-dihydroxy stratiene derivatives for pulmonary deposition |